Leslie V. Norwalk, Director of Arvinas ARVN, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $2.3M. The latest trade was on 06/24.

LN

LN

Leslie V. Norwalk

Director

Company

Arvinas ARVN

First filing

23/02/21

Trades

62 trades

Buys / sales

0 / 10

12-month net buying

−$2.3M

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	06/04	06/08	1,250 sh	$168.06	$210,075	−30.6%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	05/12	05/14	3,810 sh	$155.01	$590,588.1	−61.1%
Globus MedicalGMED	Open-market sale10b5-1 plan	01/08	01/12	2,000 sh	$101.10	$202,200	−16.1%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	25/12/15–25/12/16	25/12/17	6,190 sh2 trades	$152.78avg.	$945,707.1	−49.8%
Globus MedicalGMED	Open-market sale10b5-1 plan	25/12/12	25/12/16	4,000 sh	$88.85	$355,400	−24.4%
Globus MedicalGMED	Open-market sale10b5-1 plan	24/07/11	24/07/15	1,000 sh	$70.00	$70,000	−5.7%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/05/17	24/05/21	1,106 sh	$141.82	$156,852.92	−52.7%
Globus MedicalGMED	Open-market sale10b5-1 plan	24/03/15	24/03/19	10,590 sh	$51.99	$550,574.1	−37.8%
Neurocrine BiosciencesNBIX	Open-market sale10b5-1 plan	24/02/27	24/02/29	8,000 sh	$135.67	$1,085,360	−100.0%